نتایج جستجو برای: fibroblastic growth factor receptor 1 fgfr1

تعداد نتایج: 4125718  

2017
Krittiya Korphaisarn Jonathan M. Loree Van Nguyen Ryanne Coulson Vijaykumar Holla Beate C. Litzenburger Ken Chen Gordon B. Mills Dipen M. Maru Funda Meric-Bernstan Kenna R. Mills Shaw Scott Kopetz

We present the case of a 53-year-old male with metastatic rectal cancer who was treatment resistant to FOLFOX and FOLFOXIRI. Due to a Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation, regorafenib was given in the third line setting. Surprisingly, the patient had a prolonged partial response that lasted 27 months. Mutational status was extensively evaluated to identify potential altera...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Konstantin Agelopoulos Günther H S Richter Eva Schmidt Uta Dirksen Kristina von Heyking Benjamin Moser Hans-Ulrich Klein Udo Kontny Martin Dugas Kathrin Poos Eberhard Korsching Thorsten Buch Matthias Weckesser Isabell Schulze Regina Besoke Anika Witten Monika Stoll Gabriele Köhler Wolfgang Hartmann Eva Wardelmann Claudia Rossig Daniel Baumhoer Heribert Jürgens Stefan Burdach Wolfgang E Berdel Carsten Müller-Tidow

PURPOSE A low mutation rate seems to be a general feature of pediatric cancers, in particular in oncofusion gene-driven tumors. Genetically, Ewing sarcoma is defined by balanced chromosomal EWS/ETS translocations, which give rise to oncogenic chimeric proteins (EWS-ETS). Other contributing somatic mutations involved in disease development have only been observed at low frequency. EXPERIMENTAL...

2012
Francesca Riuzzi Guglielmo Sorci Sara Beccafico Rosario Donato

In high-density myoblast cultures S100B enhances basic fibroblast growth factor (bFGF) receptor 1 (FGFR1) signaling via binding to bFGF and blocks its canonical receptor, receptor for advanced glycation end-products (RAGE), thereby stimulating proliferation and inhibiting differentiation. Here we show that upon skeletal muscle injury S100B is released from myofibers with maximum release at day ...

2015
Devon Marc Fagel

Chronic perinatal hypoxia causes a significant loss of total brain volume, brain weight and cortical neuron number. These measures are completely reversed following recovery in normoxic conditions. Yet, the cellular and molecular mechanisms underlying this plasticity are not well understood. Here, we show that hypoxia from postnatal days 3 (P3) to 10-11 causes a 30% decrease in cortical neurons...

2015
Christopher Terranova Sridhar T. Narla Yu-Wei Lee Jonathan Bard Abhirath Parikh Ewa K. Stachowiak Emmanuel S. Tzanakakis Michael J. Buck Barbara Birkaya Michal K. Stachowiak

Genetic studies have placed the Fgfr1 gene at the top of major ontogenic pathways that enable gastrulation, tissue development and organogenesis. Using genome-wide sequencing and loss and gain of function experiments the present investigation reveals a mechanism that underlies global and direct gene regulation by the nuclear form of FGFR1, ensuring that pluripotent Embryonic Stem Cells differen...

The receptors 1 and 2 of fibroblast growth factor (FGFR1 and FGFR2, respectively) have been observed in all types of testicular cells. Culture on extracellular matrix (ECM) has been observed to lead to initiation of differentiation in spermatogonial stem cells (SSCs). The present study was carried out to investigate whether FGFR1 and FGFR2 play a role in SSCs differentiation. Following isolatio...

2006
Akio Matsubara Mikio Kan Shuju Feng Wallace L. McKeehan

A loss of expression of fibroblast growth factor (FGF) receptor 2 IHb (FGFR2IIIb), which responds to stroma-derived FGF, accompanies pro gression of premalignant androgen-responsive rat prostate tumor epithe lial cells to the malignant phenotype. Concurrently, the level of FGFR2 gene expression is reduced and lost altogether in over 30% of cells, whereas all malignant cells abnormally express F...

Journal: :Cancer research 2000
D Aviezer S Cotton M David A Segev N Khaselev N Galili Z Gross A Yayon

Fibroblast growth factors (FGFs) and vascular endothelial growth factor (VEGF) play a pivotal role in the multistep pathway of tumor progression, metastasis, and angiogenesis. We have identified a porphyrin analogue, 5,10,15,20-tetrakis(methyl-4-pyridyl)-21H,23H-porphine-tetra -p-tosylate salt (TMPP), as a potent inhibitor of FGF2 and VEGF receptor binding and activation. TMPP demonstrated pote...

2016
Wenya Zhou Xiaoling Du Fengju Song Hong Zheng Kexin Chen Wei Zhang Jilong Yang

BACKGROUND Malignant peripheral nerve sheath tumors (MPNST) are rare, highly malignant, and poorly understood sarcomas. The often poor outcome of MPNST highlights the necessity of identifying prognostic predictors for this aggressive sarcoma. Here, we investigate the role of fibroblast growth factor receptor (FGFR) family members in human MPNSTs. RESULTS aCGH and bioinformatics analysis ident...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید